CDK12 and Ewing sarcoma: A notable example is THZ-531, an ATP-site-directed covalent inhibitor that irreversibly binds CDK12/13 and synergizes with PARP inhibitors in models of hepatocellular carcinoma and Ewing sarcoma [20].